Wang Jianhua, Brown Craig, Shi Ce, Townsend Justin, Gameiro Giovana Rosa, Wang Peng, Jiang Hong
1Bascom Palmer Eye Institute, University of Miami, Miller School of Medicine, 1638 NW 10th Avenue, McKnight Building - Room 202A, Miami, FL 33136 USA.
2Department of Ophthalmology, College of Medicine, University of Arkansas for Medical Sciences, Fayetteville, AR USA.
Eye Vis (Lond). 2019 Jul 22;6:21. doi: 10.1186/s40662-019-0147-0. eCollection 2019.
Homocysteine and vitamin D may play a role in the development of diabetic and hypertensive retinopathy in patients with diabetes mellitus (DM) and hypertension. Supplementing food with L-methylfolate and vitamin D theoretically may improve diabetic and hypertensive retinopathy, however, the outcome of these nutritional approaches has not been fully examined. A retrospective case review was done of cases of retinopathy reversal in patients on Ocufolin™ and a similar nonprescription multivitamin, Eyefolate™. In this study, they were administered L-methylfolate (2.7 mg and 3.0 mg, respectively) and vitamin D3 (4500 IU each). These dosages are significantly above the RDA but well below levels associated with toxicity.
Seven patients had nonproliferative diabetic retinopathy (NPDR) and some of them had hypertension. One patient had only hypertensive retinopathy. All patients were instructed to take Ocufolin™ medical food as a food supplement. Baseline genetic testing for MTHFR polymorphisms was conducted. Fundus photography was used to document the fundus condition of the enrolled eyes in 8 NPDR patients at the initial and follow-up visits. Microaneurysms (MA) and exudates were observed to be improved in some trial patients. All subjects had one or more MTHFR polymorphisms. All had diabetic retinopathy, hypertensive retinopathy, or both. MAs were resolved, and exudates were decreased in 8/8 cases after taking the medical food. Retinal edema was found in 2/8 cases and improved or resolved in both cases after taking the medical food or the supplement. The best corrected visual activity was stable or improved in 8/8 cases.
We report a series of diabetic and hypertensive retinopathy cases with MTHFR polymorphisms and the improvement of retinal microvasculature (mainly MAs) in serial fundus photography after taking a medical food or supplement containing L-methylfolate and vitamin D. It appears that the use of nutritional supplements and medical foods containing L-methylfolate and vitamin D may be effective in facilitating the improvement of diabetic and hypertensive retinopathy.
同型半胱氨酸和维生素D可能在糖尿病(DM)和高血压患者的糖尿病性及高血压性视网膜病变发展中起作用。理论上,在食物中补充L-甲基叶酸和维生素D可能改善糖尿病性及高血压性视网膜病变,然而,这些营养方法的结果尚未得到充分检验。对服用Ocufolin™和类似非处方多种维生素Eyefolate™的视网膜病变逆转病例进行了回顾性病例分析。在本研究中,给予患者L-甲基叶酸(分别为2.7毫克和3.0毫克)和维生素D3(各4500国际单位)。这些剂量显著高于推荐膳食摄入量(RDA),但远低于与毒性相关的水平。
7例患者患有非增殖性糖尿病视网膜病变(NPDR),其中一些患者患有高血压。1例患者仅患有高血压性视网膜病变。所有患者均被指示服用Ocufolin™医用食品作为食品补充剂。进行了MTHFR基因多态性的基线基因检测。眼底摄影用于记录8例NPDR患者入组眼在初诊和随访时的眼底状况。在一些试验患者中观察到微动脉瘤(MA)和渗出物有所改善。所有受试者均有一种或多种MTHFR基因多态性。所有患者均患有糖尿病性视网膜病变、高血压性视网膜病变或两者皆有。服用医用食品后,8/8的病例中MA消退,渗出物减少。8/8的病例中发现视网膜水肿,服用医用食品或补充剂后两例均有所改善或消退。8/8的病例中最佳矫正视力稳定或提高。
我们报告了一系列伴有MTHFR基因多态性的糖尿病性和高血压性视网膜病变病例,以及在服用含有L-甲基叶酸和维生素D的医用食品或补充剂后,系列眼底摄影中视网膜微血管(主要是MA)得到改善的情况。看来,使用含有L-甲基叶酸和维生素D的营养补充剂和医用食品可能有效地促进糖尿病性和高血压性视网膜病变的改善。